VERITY Wealth Advisors’s AbbVie ABBV Stock Holding History

VERITY Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$219K	Buy	+872	New	+$188K	0.13%	76
2025 Q4	–	Sell	-872	Closed	-$202K	–	83
2025 Q3	$202K	Buy	+872	New	+$178K	0.13%	78
2023 Q2	–	Sell	-1,324	Closed	-$211K	–	70
2023 Q1	$211K	Buy	+1,324	New	+$202K	0.2%	69

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

VERITY Wealth Advisors's ABBV Position: Q2 2026 in Review

VERITY Wealth Advisors opened a new position in AbbVie (ABBV) in Q2 2026: 872 shares worth $219K. The stake represents 0.13% of the portfolio and ranks #76 among its holdings. This is a return to the name: VERITY Wealth Advisors previously reported a position in ABBV as recently as Q3 2025.

VERITY Wealth Advisors first reported a position in ABBV in Q1 2023 and has held it in 3 quarters since. 1,885 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

VERITY Wealth Advisors held 872 shares of AbbVie worth $219K as of Q2 2026.
AbbVie was a new VERITY Wealth Advisors position in Q2 2026.
AbbVie made up 0.13% of VERITY Wealth Advisors's portfolio in Q2 2026, its #76 holding.
VERITY Wealth Advisors first reported a position in AbbVie in Q1 2023 and has held it in 3 quarters since.
1,885 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on VERITY Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.